BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28796039)

  • 1. Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer.
    Zhang Q; Qu H; Sun G; Li Z; Ma S; Shi Z; Zhao E; Zhang H; He Q
    Medicine (Baltimore); 2017 Aug; 96(32):e7560. PubMed ID: 28796039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of early postoperative tumor marker response in gastric cancer.
    Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
    Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer].
    Cheng Y; Huang J; Zhu Z; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
    Jing R; Cui M; Ju S; Pan S
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
    Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
    Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
    J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
    Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
    Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study.
    Lin MQ; Wang JB; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; He QL; Huang CM
    BMC Cancer; 2019 Jan; 19(1):21. PubMed ID: 30616588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study.
    Xiao J; Ye ZS; Wei SH; Zeng Y; Lin ZM; Wang Y; Teng WH; Chen LC
    World J Gastroenterol; 2017 Dec; 23(48):8562-8569. PubMed ID: 29358864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
    Gong X; Zhang H
    J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: a case-control study.
    Jun KH; Lee JS; Kim JH; Kim JJ; Chin HM; Park SM
    Int J Surg; 2014; 12(9):893-6. PubMed ID: 25026311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.